- Home
- SPME vs OSRHW Comparison
SPME vs OSRHW Comparison
Compare SPME & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SPME | OSRHW |
|---|---|---|
| Founded | N/A | N/A |
| Country | | United States |
| Employees | N/A | 21 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | SPME | OSRHW |
|---|---|---|
| Price | $25.26 | $0.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.8K | ★ 30.2K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.73 | $0.03 |
| 52 Week High | $26.00 | $0.08 |
Technical Indicators
Market Signals| Indicator | SPME | OSRHW |
|---|---|---|
| Relative Strength Index (RSI) | 50.89 | 45.14 |
| Support Level | $25.09 | $0.06 |
| Resistance Level | $25.33 | $0.07 |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 24.64 | 0.00 |
Price Performance
Historical ComparisonAbout SPME Sound Point Meridian Capital Inc.
Sound Point Meridian Capital Inc is a closed-end management investment company. The Company's primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.
About OSRHW OSR Holdings Inc. Warrant
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.